More details to be announced.
This article examines key requirements of the “Safety Features” Delegated Regulation and discusses the implications for pharmaceutical manufacturers and other participants in the European pharmaceutical supply chain.
Issue 28- March 2016
Come check out our very own Christoph Krahelbuhl at the 3rd Serialization Symposium in Philadelphia!
Drug Supply Chain Security Act – Get ready for the future today!
There are a few opportunities to attend GTT this spring! Catch us on the East Coast in New Jersey or join us on the West Coast in California’s San Diego and/or San Francisco.
MANCHESTER, England, Feb. 16, 2016— 2016 is an exciting year for Excellis Health Solutions. As the leading provider of Life Sciences and Healthcare consulting services, Excellis is eager to reveal the recent acquisition of 3C Integrity, a specialized pharmaceutical consulting company based out of Manchester, UK.
Join subject matter experts from AmerisourceBergen, Excellis Health Solutions and Acsis as we discuss the next phase of the DSCSA requirements, with a focus on warehousing and distribution. In this webinar, moderated by Pharmaceutical Commerce, we will review where our industry is today on the journey toward full DSCSA compliance and how companies can benefit from going beyond compliance.
Learn about DSCSA and other global regulatory requirements impacting the industry and specifically, your company from 2015-2023. Find out how these regulations can help transform business processes across your enterprise. CEO of Excellis Health Solutions, Greg Cathcart, will be leading a discussion on gaining a perspective on the latest global regulations and planning and implementing your Global Serialization Initiative. The interactive presentation will offer best practices and strategies for updated serialization programs.
When: December 15, 2015
Time: 1:00 pm
Who: Greg Cathcart, Excellis Health Solutions CEO
For more details, click here.
Caitrin O’Shea, a Wisconsin School of Business MBA 2015 graduate and Excellis Health Solutions employee, shares her story on how one of her associate professor’s lessons changed her life and helped her career.
How taking a comprehensive approach in 2015 can save millions in 2023.
The Medicines and Healthcare Products Regulatory Agency (MHRA) published a press release about a huge counterfeit case in the United Kingdom. Fake medicinal products that were estimated to be worth around 15.8 million British Pounds, has been seized in the UK.
This operation–dubbed “Pangea VIII”–was coordinated by Interpol and has lead to 156 arrests worldwide, according to GMP News.
Source: GMP News